توقعات سوق علاج بيلة دموية في الشرق الأوسط وأفريقيا حتى عام 2028 - تأثير فيروس كورونا (COVID-19) والتحليل الإقليمي حسب العلاج (الأدوية والعلاجات وغيرها)، والمؤشرات (التهابات المسالك البولية، وحصوات الكلى، والتهاب الإحليل، وسرطان الدم، وحصوات المثانة، وسرطان البروستاتا، والتهاب المثانة) ، الصدمة، التمرينات القوية، مرض الكلى المتعدد الكيسات، بطانة الرحم، والحيض)، النوع (بيلة دموية مجهرية، بيلة دموية مجهرية، بيلة دموية مجهولة السبب، وبيلة دموية في الركض)، المستخدم النهائي (المستشفيات والعيادات ومراكز الجراحة المتنقلة وغيرها)

TABLE OF CONTENTS

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Middle East & Africa Hematuria Treatment Market – By Treatment

1.3.2        Middle East & Africa Hematuria Treatment Market – By Indication

1.3.3        Middle East & Africa Hematuria Treatment Market – By Type

1.3.4        Middle East & Africa Hematuria Treatment Market – By End User

1.3.5        Middle East & Africa Hematuria Treatment Market – By Country

2.           Middle East & Africa Hematuria Treatment Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Hematuria Treatment Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Middle East & Africa – PEST Analysis

4.3         Experts Opinion

5.           Hematuria Treatment Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        High Prevalence of Hematuria-Associated Indications

5.1.2        Increasing Awareness About Treatment Options and Improving Healthcare Expenditure

5.2         Market Restraints

5.2.1        Undiagnosed Cases of Associated Indications

5.3         Market Opportunities

5.3.1        Increasing Opportunities for Related Treatments

5.4         Future Trends

5.4.1        Rise in Preference for Advanced Therapies

5.5         Impact Analysis

6.           Hematuria Treatment Market – Middle East & Africa Analysis

6.1         Middle East & Africa Hematuria Treatment Market Revenue Forecast and Analysis

7.           Hematuria Treatment Market Revenue and Forecast To 2028 – By Treatment

7.1         Overview

7.2         Middle East & Africa Hematuria Treatment Market Share by Treatment 2020 & 2028 (%)

7.3         Drugs

7.3.1        Overview

7.3.2        Drugs: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

7.4         Therapies

7.4.1        Overview

7.4.2        Therapies: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

7.5         Others

7.5.1        Overview

7.5.2        Others: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.           Hematuria Treatment Market Revenue and Forecast To 2028 – By Indication

8.1         Overview

8.2         Middle East & Africa Hematuria Treatment Market Share by Indication 2020 & 2028 (%)

8.3         Kidney Stones

8.3.1        Overview

8.3.2        Kidney Stones: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.4         Urinary Tract Infections (UTI)

8.4.1        Overview

8.4.2        Urinary Tract Infections: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.5         Urethritis

8.5.1        Overview

8.5.2        Urethritis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.6         Blood Cancer

8.6.1        Overview

8.6.2        Blood Cancer: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.7         Bladder Stones

8.7.1        Overview

8.7.2        Bladder Stones: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.8         Prostate Cancer

8.8.1        Overview

8.8.2        Prostate Cancer: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.9         Cystitis

8.9.1        Overview

8.9.2        Cystitis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.10      Trauma

8.10.1     Overview

8.10.2     Trauma: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.11      Vigorous Exercise

8.11.1     Overview

8.11.2     Vigorous Exercise: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.12      Polycystic Kidney Disease

8.12.1     Overview

8.12.2     Polycystic Kidney Disease: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.13      Endometriosis

8.13.1     Overview

8.13.2     Endometriosis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.14      Menstruation

8.14.1     Overview

8.14.2     Menstruation: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

9.           Hematuria Treatment Market Revenue and Forecast To 2028 – By Type

9.1         Overview

9.2         Middle East & Africa Hematuria Treatment Market, By Type 2020 & 2028 (%)

9.3         Macroscopic Hematuria

9.3.1        Overview

9.3.2        Macroscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

9.4         Microscopic Hematuria

9.4.1        Overview

9.4.2        Microscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

9.5         Idiopathic Hematuria

9.5.1        Overview

9.5.2        Idiopathic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

9.6         Jogger’s Hematuria

9.6.1        Overview

9.6.2        Jogger’s Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

10.        Hematuria Treatment Market Revenue and Forecast To 2028 – By End User

10.1      Overview

10.2      Middle East & Africa Hematuria Treatment Market Share by End User 2020 & 2028 (%)

10.3      Hospitals

10.3.1     Overview

10.3.2     Hospitals: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

10.4      Clinics

10.4.1     Overview

10.4.2     Clinics: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

10.5      Ambulatory Surgical Centers (ASC’s)

10.5.1     Overview

10.5.2     Ambulatory Surgical Centers: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

10.6      Others

10.6.1     Overview

10.6.2     Others: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

11.        Middle East & Africa Hematuria Treatment Market – Geographic Analysis

11.1      Middle East & Africa: Hematuria Treatment Market

11.1.1     Middle East & Africa: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)

11.1.2     Middle East & Africa: Hematuria Treatment Market, by Treatment- Revenue and Forecast to 2028 (USD Million)

11.1.3     Middle East & Africa: Hematuria Treatment Market, by Indication - Revenue and Forecast to 2028 (USD Million)

11.1.4     Middle East & Africa: Hematuria Treatment Market, by Type- Revenue and Forecast to 2028 (USD Million)

11.1.5     Middle East & Africa: Hematuria Treatment Market, by End User- Revenue and Forecast to 2028 (USD Million)

11.1.6     Middle East & Africa: Hematuria Treatment Market, by Country, 2021& 2028 (%)

11.1.6.1       Saudi Arabia: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)

11.1.6.1.1       Saudi Arabia: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)

11.1.6.1.2       Saudi Arabia: Hematuria Treatment Market, by Treatment- Revenue and Forecast to 2028 (USD Million)

11.1.6.1.3       Saudi Arabia: Hematuria Treatment Market, by Indication- Revenue and Forecast to 2028 (USD Million)

11.1.6.1.4       Saudi Arabia: Hematuria Treatment Market, by Type- Revenue and Forecast to 2028 (USD Million)

11.1.6.1.5       Saudi Arabia: Hematuria Treatment Market, by End User- Revenue and Forecast to 2028 (USD Million)

11.1.6.2       South Africa: Hematuria Treatment Market- Revenue and Forecast to 2028 (USD Million)

11.1.6.2.1       South Africa: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)

11.1.6.2.2       South Africa: Hematuria Treatment Market, by Treatment- Revenue and Forecast to 2028 (USD Million)

11.1.6.2.3       South Africa: Hematuria Treatment Market, by Indication- Revenue and Forecast to 2028 (USD Million)

11.1.6.2.4       South Africa: Hematuria Treatment Market, by Type- Revenue and Forecast to 2028 (USD Million)

11.1.6.2.5       South Africa: Hematuria Treatment Market, by End User- Revenue and Forecast to 2028 (USD Million)

11.1.6.3       UAE: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)

11.1.6.3.1       UAE: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)

11.1.6.3.2       UAE: Hematuria Treatment Market, by Treatment- Revenue and Forecast to 2028 (USD Million)

11.1.6.3.3       UAE: Hematuria Treatment Market, by Indication- Revenue and Forecast to 2028 (USD Million)

11.1.6.3.4       UAE: Hematuria Treatment Market, by Type - Revenue and Forecast to 2028 (USD Million)

11.1.6.3.5       UAE: Hematuria Treatment Market, by End User- Revenue and Forecast to 2028 (USD Million)

11.1.6.4       Rest of Middle East & Africa: Hematuria Treatment Market- Revenue and Forecast to 2028 (USD Million)

11.1.6.4.1       Rest of Middle East & Africa: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)

11.1.6.4.2       Rest of Middle East & Africa: Hematuria Treatment Market, by Treatment- Revenue and Forecast to 2028 (USD Million)

11.1.6.4.3       Rest of Middle East & Africa: Hematuria Treatment Market, by Indication- Revenue and Forecast to 2028 (USD Million)

11.1.6.4.4       Rest of Middle East & Africa: Hematuria Treatment Market, by Type- Revenue and Forecast to 2028 (USD Million)

11.1.6.4.5       Rest of Middle East & Africa: Hematuria Treatment Market, by End User- Revenue and Forecast to 2028 (USD Million)

12.        Impact Of COVID-19 Pandemic on Hematuria Treatment Market

12.1      Middle East & Africa: Impact Assessment of COVID-19 Pandemic

13.        Hematuria Treatment Market–Industry Landscape

13.1      Overview

13.2      Growth Strategies Done by the Companies in the Market, (%)

13.3      Organic Developments

13.3.1     Overview

13.4      Inorganic Developments

13.4.1     Overview

14.        Company Profiles

14.1      AstraZeneca

14.1.1     Key Facts

14.1.2     Business Description

14.1.3     Products and Services

14.1.4     Financial Overview

14.1.5     SWOT Analysis

14.1.6     Key Developments

14.2      Bristol-Myers Squibb Company

14.2.1     Key Facts

14.2.2     Business Description

14.2.3     Products and Services

14.2.4     Financial Overview

14.2.5     SWOT Analysis

14.2.6     Key Developments

14.3      F. HOFFMANN-LA ROCHE LTD.

14.3.1     Key Facts

14.3.2     Business Description

14.3.3     Products and Services

14.3.4     Financial Overview

14.3.5     SWOT Analysis

14.3.6     Key Developments

14.4      GlaxoSmithKline Plc

14.4.1     Key Facts

14.4.2     Business Description

14.4.3     Products and Services

14.4.4     Financial Overview

14.4.5     SWOT Analysis

14.4.6     Key Developments

14.5      Janssen Pharmaceuticals

14.5.1     Key Facts

14.5.2     Business Description

14.5.3     Products and Services

14.5.4     Financial Overview

14.5.5     SWOT Analysis

14.5.6     Key Developments

14.6      Merck & Co., Inc.

14.6.1     Key Facts

14.6.2     Business Description

14.6.3     Products and Services

14.6.4     Financial Overview

14.6.5     SWOT Analysis

14.6.6     Key Developments

14.7      Novartis AG

14.7.1     Key Facts

14.7.2     Business Description

14.7.3     Products and Services

14.7.4     Financial Overview

14.7.5     SWOT Analysis

14.7.6     Key Developments

14.8      Pfizer Inc.

14.8.1     Key Facts

14.8.2     Business Description

14.8.3     Products and Services

14.8.4     Financial Overview

14.8.5     SWOT Analysis

14.8.6     Key Developments

14.9      Sun Pharmaceutical Industries Ltd

14.9.1     Key Facts

14.9.2     Business Description

14.9.3     Products and Services

14.9.4     Financial Overview

14.9.5     SWOT Analysis

14.9.6     Key Developments

14.10   Boehringer Ingelheim International GmbH

14.10.1  Key Facts

14.10.2  Business Description

14.10.3  Products and Services

14.10.4  Financial Overview

14.10.5  SWOT Analysis

14.10.6  Key Developments

15.        Appendix

15.1      About The Insight Partners

15.2      Glossary of Terms

LIST OF TABLES

Table 1.             Middle East & Africa Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

Table 2.             Middle East & Africa Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 3.             Middle East & Africa Hematuria Treatment Market, by Type– Revenue and Forecast to 2028 (USD Million)

Table 4.             Middle East & Africa Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 5.             Saudi Arabia Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

Table 6.             Saudi Arabia Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 7.             Saudi Arabia Hematuria Treatment Market, by Type– Revenue and Forecast to 2028 (USD Million)

Table 8.             Saudi Arabia Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 9.             South Africa Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

Table 10.          South Africa Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 11.          South Africa Hematuria Treatment Market, by Type– Revenue and Forecast to 2028 (USD Million)

Table 12.          South Africa Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 13.          UAE Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

Table 14.          UAE Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 15.          UAE Hematuria Treatment Market, by Type– Revenue and Forecast to 2028 (USD Million)

Table 16.          UAE Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 17.          Rest of Middle East & Africa Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

Table 18.          Rest of Middle East & Africa Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 19.          Rest of Middle East & Africa Hematuria Treatment Market, by Type– Revenue and Forecast to 2028 (USD Million)

Table 20.          Rest of Middle East & Africa Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 21.          Organic Developments Done by Companies

Table 22.          Inorganic Developments Done by Companies

Table 23.          Glossary of Terms, Hematuria Treatment Market

LIST OF FIGURES

Figure 1.           Hematuria Treatment Market Segmentation

Figure 2.           Middle East & Africa Hematuria Treatment Market Overview

Figure 3.           Macroscopic Hematuria Segment Held the Largest Share of the Type Segment in Hematuria Treatment Market

Figure 4.           UAE to Show Significant Growth During Forecast Period

Figure 5.           Middle East & Africa Hematuria Treatment Market, Industry Landscape

Figure 6.           Middle East & Africa PEST Analysis

Figure 7.           Hematuria Treatment Market Impact Analysis of Drivers and Restraints

Figure 8.           Middle East & Africa Hematuria Treatment Market – Revenue Forecast and Analysis – 2020- 2028

Figure 9.           Middle East & Africa Hematuria Treatment Market Share by Treatment 2020 & 2028 (%)

Figure 10.        Drugs: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 11.        Therapies: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 12.        Others: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 13.        Middle East & Africa Hematuria Treatment Market Share by Indication 2020 & 2028 (%)

Figure 14.        Kidney Stones: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 15.        Urinary Tract Infections: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 16.        Urethritis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 17.        Blood Cancer: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 18.        Bladder Stones: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 19.        Prostate Cancer: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 20.        Cystitis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 21.        Trauma: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 22.        Vigorous Exercise: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 23.        Polycystic Kidney Disease: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 24.        Endometriosis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 25.        Menstruation: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 26.        Middle East & Africa Hematuria Treatment Market, by Type 2020 & 2028 (%)

Figure 27.        Macroscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

Figure 28.        Microscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

Figure 29.        Idiopathic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

Figure 30.        Jogger’s Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

Figure 31.        Middle East & Africa Hematuria Treatment Market Share by End User 2020 & 2028 (%)

Figure 32.        Hospitals: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 33.        Clinics: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 34.        Ambulatory Surgical Centers: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 35.        Others: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 36.        Middle East & Africa: Hematuria Treatment Market, by Key Country – Revenue (2021) (USD Million)

Figure 37.        Middle East & Africa Hematuria Treatment Market Revenue and Forecast to 2028 (USD Million)

Figure 38.        Middle East & Africa: Hematuria Treatment Market, by Country, 2021& 2028 (%)

Figure 39.        Saudi Arabia: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)

Figure 40.        South Africa: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)

Figure 41.        UAE: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)

Figure 42.        Rest of Middle East & Africa: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)

Figure 43.        Impact Of COVID-19 Pandemic in Middle East & Africa Country Markets

Figure 44.        Growth Strategies Done by the Companies in the Market, (%)

1. AstraZeneca
2. Bristol-Myers Squibb Company
3. F. HOFFMANN-LA ROCHE LTD.
4. GlaxoSmithKline plc.
5. Janssen Pharmaceuticals
6. Merck & Co., Inc.
7. Novartis AG
8. Pfizer Inc.
9. Sun Pharmaceutical Industries Ltd
10. Boehringer Ingelheim International GmbH

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa hematuria treatment market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa hematuria treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.